Simulations Plus (SLP) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
12 Feb, 2026Opening remarks and agenda
The meeting was called to order by the CEO, who outlined the agenda and rules of conduct, emphasizing inclusivity via the virtual format.
Board and executive committee updates
Four individuals were nominated for election to the board, with recommendations for approval.
Shareholder proposals
Four proposals were presented: election of directors, ratification of the independent auditor, amendment to the equity incentive plan, and advisory vote on executive compensation frequency.
The board recommended approval for all proposals, including a three-year frequency for executive compensation votes.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Simulations Plus
- Q3 FY26 revenue up 7%, services up 20%, net income $3.6M, merger at $18.50/share pending.SLP
Q3 20269 Jul 2026 - Shareholders to vote on $18.50/share cash merger, with board unanimous support and 26% premium.SLP
Proxy filing9 Jul 2026 - FY24 revenue up 18% to $70M; FY25 guidance strong with Pro-ficiency driving growth.SLP
Q4 20249 Jul 2026 - FY25 guidance targets $90M-$93M revenue, 31%-33% EBITDA margin, and expanded market reach.SLP
Stephens 26th Annual Investment Conference | NASH20248 Jul 2026 - Q1 revenue fell 3% to $18.4M as services rose 16%, software dropped 17%, and guidance was reaffirmed.SLP
Q1 20268 Jul 2026 - $100M acquisition doubles market, expands platform, and boosts 2025 EPS outlook.SLP
M&A Announcement8 Jul 2026 - OBESITYsym predicts weight loss and nausea for obesity drugs, validated across diverse populations.SLP
Status update23 Jun 2026 - Q2 2026 revenue up 8% to $24.3M, with higher margins and strong outlook despite EPS guidance cut.SLP
Q2 202610 Apr 2026 - Integrated AI ecosystem and cross-selling drive future growth, with major upside in FY 2027.SLP
TD Cowen 46th Annual Health Care Conference3 Mar 2026